First Manhattan’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-775
| Closed | -$31.8K | – | 1522 |
|
|
2023
Q2 | $31.8K | Sell |
775
-775
| -50% | -$29.8K | ﹤0.01% | 962 |
|
|
2023
Q1 | $55.4K | Sell |
1,550
-425
| -22% | -$16K | ﹤0.01% | 900 |
|
|
2022
Q4 | $74.6K | Hold |
1,975
| – | – | ﹤0.01% | 872 |
|
|
2022
Q3 | $87K | Hold |
1,975
| – | – | ﹤0.01% | 837 |
|
|
2022
Q2 | $73K | Buy |
1,975
+775
| +65% | +$29.2K | ﹤0.01% | 901 |
|
|
2022
Q1 | $44K | Hold |
1,200
| – | – | ﹤0.01% | 1029 |
|
|
2021
Q4 | $36K | Hold |
1,200
| – | – | ﹤0.01% | 1052 |
|
|
2021
Q3 | $40K | Hold |
1,200
| – | – | ﹤0.01% | 1029 |
|
|
2021
Q2 | $47K | Sell |
1,200
-374,100
| -100% | -$14.7M | ﹤0.01% | 998 |
|
|
2021
Q1 | $16.9M | Buy |
375,300
+170,900
| +84% | +$9.53M | 0.07% | 124 |
|
|
2020
Q4 | $11.6M | Sell |
204,400
-110
| -0.1% | -$5.48K | 0.06% | 147 |
|
|
2020
Q3 | $9.7M | Buy |
204,510
+203,260
| +16,261% | +$11.3M | 0.05% | 146 |
|
|
2020
Q2 | $73K | Hold |
1,250
| – | – | ﹤0.01% | 820 |
|
|
2020
Q1 | $59K | Hold |
1,250
| – | – | ﹤0.01% | 817 |
|
|
2019
Q4 | $75K | Sell |
1,250
-25
| -2% | -$1.49K | ﹤0.01% | 839 |
|
|
2019
Q3 | $76K | Hold |
1,275
| – | – | ﹤0.01% | 842 |
|
|
2019
Q2 | $81K | Buy |
1,275
+1,225
| +2,450% | +$86.6K | ﹤0.01% | 857 |
|
|
2019
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 1285 |
|
|
2018
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 1298 |
|
|
2018
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 1339 |
|
|
2018
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 1297 |
|
|
2018
Q1 | $2K | Sell |
50
-1,114
| -96% | -$56.6K | ﹤0.01% | 1309 |
|
|
2017
Q4 | $58K | Buy |
1,164
+314
| +37% | +$17.2K | ﹤0.01% | 968 |
|
|
2017
Q3 | $43K | Buy |
850
+800
| +1,600% | +$41.9K | ﹤0.01% | 985 |
|
|
2017
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 1320 |
|
|
2017
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 1332 |
|
|
2016
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 1315 |
|
|
2016
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 1353 |
|
|
2016
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 1418 |
|
|
2016
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 1322 |
|
|
2015
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 1305 |
|
|
2015
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 1352 |
|
|
2015
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 1368 |
|
|
2015
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 1358 |
|
|
2014
Q4 | $3K | Sell |
50
-1,000
| -95% | -$49.3K | ﹤0.01% | 1382 |
|
|
2014
Q3 | $40K | Hold |
1,050
| – | – | ﹤0.01% | 1002 |
|
|
2014
Q2 | $36K | Hold |
1,050
| – | – | ﹤0.01% | 1010 |
|
|
2014
Q1 | $45K | Buy |
1,050
+1,000
| +2,000% | +$48.5K | ﹤0.01% | 975 |
|
|
2013
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 1327 |
|
|
2013
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 1328 |
|
|
2013
Q2 | $1K | Buy |
+50
| New | +$1.06K | ﹤0.01% | 1322 |
|
Other funds holding IONS
BG
BI
TBC
First Manhattan's IONS Position: Q3 2023 in Review
First Manhattan sold out of Ionis Pharmaceuticals (IONS) in Q3 2023, closing a stake of 775 shares — an estimated $31.8K sold.
First Manhattan first reported a position in IONS in Q2 2013 and held it in 41 quarters. The position peaked at $16.9M in Q1 2021. 310 funds tracked by Wall St. Rank hold IONS as of Q3 2023.
- First Manhattan reported no remaining Ionis Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
- First Manhattan sold 775 Ionis Pharmaceuticals shares in Q3 2023, an estimated $31.8K.
- First Manhattan first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 41 quarters.
- First Manhattan's Ionis Pharmaceuticals position peaked at $16.9M in Q1 2021.
- 310 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2023.
Based on First Manhattan's 13F filing for Q3 2023, filed 14 Nov 2023.